Byoung Chul Cho, MD, PhD, is a professor of internal medicine in the Division of Medical Oncology at Yonsei Cancer Center, Yonsei University College of Medicine.
Enhanced Prophylactic Regimen Reduces Skin AEs With Amivantamab-Lazertinib: Byoung Chul Cho, MD, PhD
September 9th 2025Byoung Chul Cho, MD, PhD, of the Yonsei University College of Medicine, discussed outcomes in the COCOON trial of an enhanced dermatologic regimen with amivantamab-lazertinib treatment.